Skip to main content
logo
Alembic Pharmaceuticals Limited (BOM:533573)
India flag India · Delayed Price · Currency is INR
797.05
-5.10 (-0.64%)
At close: Jul 31, 2026

Alembic Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
156,671130,370182,755193,57597,564145,771
Market Cap Growth
-20.90%-28.66%-5.59%98.41%-33.07%-23.15%
Enterprise Value
168,948143,795192,124200,785104,548151,109
Last Close Price
797.05652.14905.59946.64472.70695.86

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
23.2219.3231.3331.4328.5327.98
PS Ratio
2.131.782.743.111.732.75
PB Ratio
2.762.303.524.022.232.78
P/TBV Ratio
2.912.423.524.022.232.87
P/FCF Ratio
45.0137.45-40.6934.78115.04
P/OCF Ratio
20.0216.66207.7524.1013.4826.39

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
2.301.962.883.221.852.85
EV/EBITDA Ratio
15.1413.1019.4221.9715.0217.60
EV/EBIT Ratio
21.1918.0426.3330.3923.8825.72
EV/FCF Ratio
48.5341.31-42.2137.27119.26

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.250.250.240.110.170.14
Debt / EBITDA Ratio
1.281.281.250.551.010.82
Debt / FCF Ratio
4.114.11-1.082.575.66
Net Debt / Equity Ratio
0.220.220.230.080.150.13
Net Debt / EBITDA Ratio
1.121.121.190.430.930.76
Net Debt / FCF Ratio
3.543.54-2.470.832.315.18
Asset Turnover
0.890.890.940.990.850.77
Inventory Turnover
0.870.870.961.151.150.97
Quick Ratio
0.650.650.620.820.740.52
Current Ratio
1.761.761.702.121.781.67
Return on Equity (ROE)
12.36%12.36%11.63%13.40%7.12%10.11%
Return on Assets (ROA)
6.02%6.02%6.42%6.54%4.11%5.31%
Return on Invested Capital (ROIC)
11.36%11.62%10.38%12.59%7.74%8.69%
Return on Capital Employed (ROCE)
12.90%12.90%13.60%13.20%9.60%10.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
4.31%5.18%3.19%3.18%3.50%3.57%
FCF Yield
2.22%2.67%-2.60%2.46%2.88%0.87%
Dividend Yield
1.51%1.84%1.21%1.16%1.69%1.44%
Payout Ratio
32.04%32.04%37.06%25.54%57.48%52.83%
Buyback Yield / Dilution
------1.46%
Total Shareholder Return
1.51%1.84%1.21%1.16%1.69%-0.02%